Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update Journal Article
| Authors: | Patel, P.; Robinson, P. D.; Thackray, J.; Flank, J.; Holdsworth, M. T.; Gibson, P.; Orsey, A.; Portwine, C.; Freedman, J.; Madden, J. R.; Phillips, R.; Sung, L.; Dupuis, L. L. |
| Article Title: | Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update |
| Abstract: | This update of the 2013 clinical practice guideline provides clinicians with guidance regarding the use of aprepitant and palonosetron for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) in children. The recommendations were based on three systematic reviews. Substantive changes were made to the guideline recommendations including the inclusion of palonosetron to the 5-HT3 antagonists recommended for children receiving highly emetogenic chemotherapy (HEC) and the recommendation of aprepitant for children 6 months of age or older receiving HEC. To optimize CINV control in children, future work must focus on closing critical research gaps. © 2017 Wiley Periodicals, Inc. |
| Keywords: | chemotherapy; nausea; vomiting; pediatrics; supportive care; guideline |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 64 |
| Issue: | 10 |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2017-10-01 |
| Start Page: | e26542 |
| Language: | English |
| DOI: | 10.1002/pbc.26542 |
| PROVIDER: | scopus |
| PUBMED: | 28453189 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 September 2017 -- Source: Scopus |
